![Quantification of Atherosclerotic Plaque Activity and Vascular Inflammation using [18-F] Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography (FDG-PET/CT)](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F3777.jpg&w=3840&q=50)
FDG imaging of a pulmonary artery sarcoma
R L Thurer1, A Thorsen, J A Parker
1Division of Cardiothoracic Surgery, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts 02215, USA. rthurer@caregroup.harvard.edu
Positron emission tomography using fluorine-18-2-fluoro-2-deoxy-D-glucose aided in diagnosing a right hilar mass. This led to a right pneumonectomy, revealing a pulmonary artery sarcoma.
Area of Science:
- Oncology
- Nuclear Medicine
- Thoracic Surgery
Background:
- Diagnosis of rare thoracic tumors can be challenging.
- Accurate preoperative staging is crucial for effective treatment planning.
Observation:
- A patient presented with a right hilar mass requiring diagnostic evaluation.
- Fluorine-18-2-fluoro-2-deoxy-D-glucose-positron emission tomography (FDG-PET) was utilized for imaging.
Findings:
- FDG-PET imaging provided critical diagnostic information for the right hilar mass.
- Intraoperative findings correlated with preoperative imaging.
- The mass was confirmed to be a pulmonary artery sarcoma.
Implications:
- FDG-PET is a valuable tool in the diagnosis of complex thoracic pathologies.
- Surgical resection via right pneumonectomy can be curative for pulmonary artery sarcomas.
- This case highlights the importance of advanced imaging in identifying and managing rare tumors.
More Related Videos
10:28Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT
Published on: January 22, 2018
06:51Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
Published on: July 21, 2018
